University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Boosting Language Outcomes of Minimally Verbal Children With ASD (BLOOM)

Not Applicable

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: JASPER
Behavioral: PROMPT

First Posted Date: 2020-01-06

Last Posted Date: 2024-10-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 80

Registration Number: NCT04218331

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States
🇺🇸
UCLA, Los Angeles, California, United States

Effect of Strawberry Consumption on the Microbiome

Not Applicable

Completed

Conditions: Microbiome

Interventions: Other: placebo powder
Other: strawberry powder

First Posted Date: 2020-01-03

Last Posted Date: 2020-01-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT04217122

Locations: 🇺🇸
UCLA Center for Human Nutrition, 1000 Veteran Ave., Los Angeles, California, United States

Campus Life Study: Harnessing Generativity Among Young Adults

Not Applicable

Completed

Conditions: Healthy Young Adults

Interventions: Behavioral: Writing

First Posted Date: 2019-12-23

Last Posted Date: 2020-02-12

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 165

Registration Number: NCT04207528

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Phase 4

Terminated

Conditions: Schizophrenia
Schizophreniform Disorder
Schizoaffective Disorder, Depressive Type

Interventions: Drug: ARI-ORAL
Drug: Aripiprazole Lauroxil
Drug: AL-NCD

First Posted Date: 2019-12-18

Last Posted Date: 2023-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 15

Registration Number: NCT04203056

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

acTBS Treatment for Inpatient Subjects With Suicidality

Not Applicable

Active, not recruiting

Conditions: Suicidality

Interventions: Device: accelerated Thetaburst stimulation
Device: Sham Comparator

First Posted Date: 2019-12-13

Last Posted Date: 2024-08-12

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT04197765

Locations: 🇺🇸
Resnick Neuropsychiatric Hospital, Los Angeles, California, United States

Socially Assistive Robots to Enhance Magnification Device Use for Reading

Phase 1

Recruiting

Conditions: Low Vision

Interventions: Behavioral: Socially Assistive Robot for Low Vision Rehabilitation

First Posted Date: 2019-12-09

Last Posted Date: 2024-07-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 20

Registration Number: NCT04190134

Locations: 🇺🇸
UCLA Stein Eye Institute, Los Angeles, California, United States

Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)

Phase 4

Completed

Conditions: Pain Management

Interventions: Drug: Local anaesthetic
Drug: Pudendal Nerve Block plus anesthesia

First Posted Date: 2019-11-20

Last Posted Date: 2024-07-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 33

Registration Number: NCT04171050

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

Phase 4

Completed

Conditions: Epistaxis

Interventions: Drug: Doxycycline
Other: Placebo

First Posted Date: 2019-11-18

Last Posted Date: 2022-07-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 26

Registration Number: NCT04167085

Locations: 🇺🇸
100 UCLA Medical Plaza, Los Angeles, California, United States

Opioids and Social Support Enhanced Extinction Effects

Early Phase 1

Conditions: Fear

Interventions: Drug: Placebo
Drug: Naltrexone

First Posted Date: 2019-11-18

Last Posted Date: 2025-01-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT04166071

Locations: 🇺🇸
UCLA Department of Psychology, 5514 Pritzker Hall, Los Angeles, California, United States
🇺🇸
UCLA, Los Angeles, California, United States

Spectral Correlation Coefficient-determine TMS for Depression

Not Applicable

Conditions: Major Depressive Disorder

Interventions: Device: Transcranial magnetic Stimulation

First Posted Date: 2019-11-18

Last Posted Date: 2025-01-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 10

Registration Number: NCT04166864

Locations: 🇺🇸
UCLA Depression Research and Clinic Program, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy